Philip R. Debruyne
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults 15
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 8
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- Pancreatic and Hepatic Oncology Research 6
-
- Renal cell carcinoma treatment 16
- Lung Cancer Treatments and Mutations 7
-
- Nutrition and Health in Aging 10
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Co-authors
- Hans PottelTom BoterbergMichelle LyckeA. ZimberErik BruyneelChristian GespachLies PottelMarc Mareel
- Journals
- Journal of Clinical Oncology (12 papers)Gastroenterology (1 paper)Cancer Research (1 paper)
- Partner nations
- BelgiumUnited KingdomFrance
In The Last Decade
Philip R. Debruyne
81 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 215
- Otorhinolaryngology 139
- Oncology 678
- Pulmonary and Respiratory Medicine 453
- Cancer Research 136
Countries citing papers authored by Philip R. Debruyne
This map shows the geographic impact of Philip R. Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Debruyne more than expected).
Fields of papers citing papers by Philip R. Debruyne
This network shows the impact of papers produced by Philip R. Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Debruyne. The network helps show where Philip R. Debruyne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip R. Debruyne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 4 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 14 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 4 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 0 | |
| 15 | 2015 | 61 | |
| 16 | Could the combined test "VES-13 + (max - G8)" represent an interesting alternative screening tool for identification of potential vulnerable elderly head and neck cancer patients? | 2011 | 2 |
| 17 | 2009 | 10 | |
| 18 | 2007 | 5 | |
| 19 | 2003 | 6 | |
| 20 | The new sulindac derivative IND 12 reverses Ras-induced cell transformation. | 2002 | 25 |
About Philip R. Debruyne
Philip R. Debruyne is a scholar working on Geriatrics and Gerontology, Otorhinolaryngology and Family Practice, having authored 87 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Frailty in Older Adults (15 papers), Cancer Immunotherapy and Biomarkers (12 papers), Nutrition and Health in Aging (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Head and Neck Cancer Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Geriatrics and Gerontology (215 citations), Otorhinolaryngology (139 citations) and Oncology (678 citations). Philip R. Debruyne has collaborated with scholars based in Belgium, United Kingdom and France. Frequent co-authors include Hans Pottel, Tom Boterberg, Michelle Lycke, A. Zimber, Erik Bruyneel, Christian Gespach, Lies Pottel, Marc Mareel, Xuedong Li and Koen Van Eygen. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.